Zemuron and Jitters - a phase IV clinical study of FDA data

Summary:

Jitters is reported as a side effect among people who take Zemuron (rocuronium bromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Trasylol, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Jitters when taking Zemuron. It is created by eHealthMe based on reports of 872 people who have side effects when taking Zemuron from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Jitters?

Jitters (to make someone nervous or frightened) is found to be associated with 4,362 drugs and 5,458 conditions by eHealthMe. Check the latest studies of Jitters.

On Mar, 31, 2026

872 people reported to have side effects when taking Zemuron.
Among them, 49 people (5.62%) have Jitters.

Among these 49 people:

How long have people been on Zemuron when they have Jitters? *

What is the gender of people who have Jitters when taking Zemuron? *

female: 38.3 %
male: 61.7 %

What is the age of people who have Jitters when taking Zemuron? *

What are other drugs people take besides Zemuron? *

What are other side effects people have besides Jitters? *

Pain: 45 people, 91.84%
Injury: 43 people, 87.76%
Acute Kidney Failure: 41 people, 83.67%
Fear: 40 people, 81.63%
Emotional Distress: 40 people, 81.63%
Renal Injury (kidney injury): 36 people, 73.47%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 33 people, 67.35%
Renal Impairment (severely reduced kidney function): 33 people, 67.35%
Multi-Organ Failure (multisystem organ failure): 21 people, 42.86%
Death: 18 people, 36.73%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 6.12%
Memory Loss: 2 people, 4.08%
High Blood Pressure: 2 people, 4.08%
Type 2 Diabetes: 2 people, 4.08%
Sedation: 2 people, 4.08%
Blood Pressure Abnormal: 2 people, 4.08%
Post Procedural Haematoma (post procedural clotting of blood): 2 people, 4.08%
Pain: 2 people, 4.08%
Depression: 2 people, 4.08%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and have Jitters?

- Check whether Jitters is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemuron:

Zemuron (873 reports)

Jitters treatments and more:

Jitters (637,413 reports)

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jitters:

Jitters (4,362 drugs)

Browse all the conditions that are associated with Jitters:

Jitters (5,458 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Zemuron) and Zemuron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.